Successful achievement of sustained virological response to triple combination therapy containing simeprevir in two patients with chronic hepatitis C who had failed asunaprevir:Daclatasvir combination therapy

Publisher： John Wiley & Sons Inc

E-ISSN： 1872-034x|46|11|1162-1167

ISSN： 1386-6346

Source： HEPATOLOGY RESEARCH, Vol.46, Iss.11, 2016-10, pp. : 1162-1167

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Emergence of resistant variants detected by ultra‐deep sequencing after asunaprevir and daclatasvir combination therapy in patients infected with hepatitis C virus genotype 1

By  

JOURNAL OF VIRAL HEPATITIS (ELECTRONIC), Vol. 22, Iss. 2, 2015-02 ,pp. : 158-165

John Wiley & Sons Inc

Access to resources Recommend Favorite

Factors associated with sustained virological response in 24‐week telaprevir‐based triple therapy for chronic hepatitis C genotype 1b patients with the IL28B minor genotype

By  

HEPATOLOGY RESEARCH, Vol. 45, Iss. 4, 2015-04 ,pp. : 387-396

John Wiley & Sons Inc

Access to resources Recommend Favorite

PEG-IFNα/RBV Combination Therapy for Chronic Hepatitis C Patients Increases Serum Ferritin Level while It Improves Sustained Viral Response Rate

By  

Intervirology, Vol. 53, Iss. 1, 2010-01 ,pp. : 60-65

Karger

Access to resources Recommend Favorite

P147: A phenotypic NS3‐protease inhibitor resistance assay to characterize resistance‐associated mutations in patients

By  

JOURNAL OF VIRAL HEPATITIS (ELECTRONIC), Vol. 22, Iss. S2, 2015-06 ,pp. : 93-93

John Wiley & Sons Inc

Access to resources Recommend Favorite

P137: Assessment of outcomes of triple combination therapy including telaprevir in treating chronic hepatitis C in hemodialysis patients

By  

JOURNAL OF VIRAL HEPATITIS (ELECTRONIC), Vol. 22, Iss. S2, 2015-06 ,pp. : 88-89

John Wiley & Sons Inc

Access to resources Recommend Favorite